Standigm Alternatives & Competitors
12 companies similar to Standigm — The workflow AI drug discovery company
Companies similar to Standigm
Variational AI
State-of-the-art generative AI for small molecule drug discovery
Canada
Accutar Biotech
Employ AI to Revolutionize Drug Discovery
Brooklyn, United States
Deargen
AI-First Pharmatech Company. We are exploring sequence-based drug discovery and developmen...
Daejeon, Korea South
Rival Readout
Competing with Standigm? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
ONCOCROSS Co., Ltd.
AI, drug discovery development, biotechnology, indication expansion, rare disease, intract...
Seoul, Korea South
Vernalis
We develop and apply fragment and structure-based methods to solve problems in drug discov...
Cambridge, United Kingdom
Genesis Molecular AI
Unifying AI and Biotech to accelerate the discovery of new medicines
San Mateo, United States
Syntekabio Inc.
AI Platform for Drug Discovery & Precision Medicine (226330:KOSDAQ)
New York, United States
Transition Bio, Inc.
The only end-to-end condensate drug discovery platform built on molecular insights.
Cambridge, United States
iktos
Artificial intelligence for new drug design
Paris, France
Celeris Therapeutics
The PIC Engineering Company.
Menlo Park, United States
Ro5
Bioactivity. De Novo Drug Discovery. ADMET. Knowledge Graph.
London, United Kingdom
About Standigm
Standigm, founded in 2015, is a Korean-based company specializing in AI-driven drug discovery. With its slogan, "The workflow AI drug discovery company," Standigm leverages cutting-edge proprietary AI platforms to revolutionize the drug development process. It offers a comprehensive solution encompassing novel target i...
AI Drug Discovery, Target Identification, Lead Optimization, AI SaaS & API Solutions, Pipeline Development
Pharmaceutical Companies, Biotechnology Firms, Research Institutions, Healthcare Providers, Labs looking for AI solutions
AI-driven Drug Discovery, Workflow Automation, Molecular Design, Novel Target Identification, Lead Compound Generation, First-in-Class Drug Development, Target Discovery, Lead Design, Drug Repurposing, Deep Learning, Active Data Parsing, Bot Modeling, Biological Interpretation
B2B, SaaS, Platform
Subscription, Licensing, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Standigm: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Standigm on 21 Sep 2026. The 12 companies listed here were last checked between 29 May 2025 and 22 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
